BioCryst Pharmaceuticals, Inc. EBITDA

EBITDA of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA growth rates and interactive chart. Earnings before interest, tax, depreciation and amortization (EBITDA) is a measure of a company's operating performance. Essentially, it's a way to evaluate a company's performance without having to factor in depreciation, interest expenses (debt), writedowns or other accounting measures and taxes. EBITDA, however, can be misleading because it strips out the cost of capital investments like property, plant, and equipment. To calculate EBITDA, take operating profit (also called EBIT) and add back depreciation and amortization.

Highlights and Quick Summary

  • EBITDA for the quarter ending September 30, 2022 was $-17.8 Million (a -48.45% decrease compared to previous quarter)
  • Year-over-year quarterly EBITDA decreased by -65.82%
  • Annual EBITDA for 2021 was $-177 Million (a 1.76% increase from previous year)
  • Annual EBITDA for 2020 was $-174 Million (a 76.33% increase from previous year)
  • Annual EBITDA for 2019 was $-98.6 Million (a 6.66% increase from previous year)
  • Twelve month EBITDA ending September 30, 2022 was $-154 Million (a -14.72% decrease compared to previous quarter)
  • Twelve month trailing EBITDA decreased by -13.0% year-over-year
Trailing EBITDA for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-154 Million $-181 Million $-175 Million $-177 Million
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA of BioCryst Pharmaceuticals, Inc.

Most recent EBITDAof BCRX including historical data for past 10 years.

Interactive Chart of EBITDA of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. EBITDA for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $-17.79 $-34.51 $-49.61 –
2021 $-52.04 $-44.35 $-29.36 $-51.19 $-176.95
2020 $-53.27 $-42.32 $-37.89 $-40.42 $-173.89
2019 $-0.74 $-34.56 $-34.35 $-28.96 $-98.61
2018 $-24.9 $-28.07 $-17.77 $-21.72 $-92.46
2017 $-17.43 $-12.91 $-15.06 $-10.28 $-55.67
2016 $-7.77 $-8.75 $-11.86 $-18.66 $-47.04
2015 $-16.93 $-12.82 $5.77 $-14.28 $-38.26
2014 $-14.86 $-11.46 $-11.47 $-7.22 $-45.01
2013 $-6.17 $-6.75 $-11.95 $-5.11 $-29.97
2012 $-10.42 $-7.77 $-9.91 $-4.72 $-32.82

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com